SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-005522
Filing Date
2024-05-03
Accepted
2024-05-03 20:51:05
Documents
1
Period of Report
2024-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18231
  Complete submission text file 0001209191-24-005522.txt   19715
Mailing Address C/O SANGAMO BIOSCIENCES, INC STE-A-100 POINT RICHMOND TECH, 501 CANAL BLVD, RICHMOND CA 94804
Business Address
ZANTE GREG (Reporting) CIK: 0001264949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 24915292

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)